Artiva Biotherapeutics, Inc.
ARTV
$1.98
-$0.07-3.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.50% | 26.46% | 214.96% | -25.07% | -19.28% |
| Total Receivables | -80.37% | -14.92% | -10.25% | -9.40% | -52.35% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.99% | 105.84% | 55.21% | -19.57% | -2.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -9.87% | 25.28% | 202.65% | -24.49% | -17.46% |
|
|
|||||
| Total Current Assets | -9.87% | 25.28% | 202.65% | -24.49% | -17.46% |
| Net Property, Plant & Equipment | 1.76% | -5.04% | -5.39% | -2.72% | -5.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -9.71% | -5.58% | -83.78% | 278.78% | 39.23% |
| Total Assets | -8.74% | -7.10% | 197.18% | -15.80% | -14.23% |
|
|
|||||
| Total Accounts Payable | 81.62% | -7.74% | 47.63% | -44.50% | 141.53% |
| Total Accrued Expenses | -13.76% | -11.41% | 34.28% | 18.63% | -34.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.53% | 0.19% | -1.50% | 3.92% | 1.42% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -0.40% | -7.82% | 22.77% | 4.43% | -15.20% |
|
|
|||||
| Total Current Liabilities | -0.40% | -7.82% | 22.77% | 4.43% | -15.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.18% | -5.53% | -6.18% | -5.04% | -5.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 0.00% | -99.74% | 9.24% | 1.07% |
| Total Liabilities | -2.01% | -6.75% | -51.38% | 4.49% | -4.53% |
|
|
|||||
| Common Stock & APIC | 0.54% | 0.51% | 1,869.25% | 7.38% | 7.40% |
| Retained Earnings | -8.23% | -6.98% | -8.20% | -9.14% | -7.70% |
| Treasury Stock & Other | -- | -138.17% | 179.34% | -41.55% | -32.79% |
| Total Common Equity | -9.57% | -7.14% | 205.18% | -9.40% | -7.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -9.57% | -7.14% | 205.18% | -9.40% | -7.81% |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.57% | -7.14% | 693.95% | -39.35% | -23.27% |
|
|
|||||